I. Kennedy

发表

Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

D. Cameron, J. Crown, J. Mansi, 2002, British Journal of Cancer.

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, J. Simeone, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significant Tumor Response to the Poly (ADP-ribose) Polymerase Inhibitor Olaparib in Heavily Pretreated Patient With Ovarian Carcinosarcoma Harboring a Germline RAD51D Mutation.

I. Kennedy, Elias A Chandran, 2018, JCO precision oncology.

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.

D. Goldstein, M. Tattersall, S. Ackland, 1997, Seminars in oncology.

Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.

D. Goldstein, M. Tattersall, S. Ackland, 1997, Oncology.

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

M. Tattersall, D. Goldstein, M. Tattersall, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial P aclitaxel I mproves O utcome C ompared W ith C MFP Combination C hemotherapy a s F ront-Line T herapy in U ntreated M etastatic B reast C ancer

D. Goldstein, S. Ackland, J. Dewar, 1999 .

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

M. Krzakowski, D. Campos, J. Zaluski, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.

J. Ledermann, D. Cameron, J. Crown, 2004, Journal of the National Cancer Institute.

Characteristics and outcomes of patients with small cell lung cancer - findings from a New Zealand SACT database

R. Lawrenson, C. Lao, R. Keenan, 2023, Asia-Pacific Journal of Oncology.

Case Report: Sustained Complete Response to PI3K Inhibition in a Patient with Metastatic Breast Cancer Harboring PIK3CA, NF1, and CDH1 Mutations.

I. Kennedy, Elias A Chandran, 2020, Journal of immunotherapy and precision oncology.

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

G. Hortobagyi, R. Theriault, H. Wheeler, 1996, The New England journal of medicine.

Chemotherapy prescription patterns in colon cancer: a patterns-of-care survey in New Zealand.

M. Jameson, I. Kennedy, Jacqui Adams, 2007, The New Zealand medical journal.